References
- Bunt TJ. Vascular graft infections: an update. Cardiovascular Surgery 2001; 9: 225–33
- Reilly LM. Aortic graft infection: evolution in management. Cardiovascular Surgery 2002; 10: 372–7
- Henke PK, Bergamini TM, Rose SM, Richardson JD. Current options in prosthetic vascular graft infection. The American Surgeon 1998; 64: 39–46
- Seeger JM. Management of patients with prosthetic vascular graft infection. The American Surgeon 2000; 66: 166–77
- Jones L, Braithwaite BD, Davies B, Heather BP, Earnshaw JJ. Mechanism of late prosthetic graft infection. Cardiovascular Surgery 1997; 5: 486–489
- Calligaro KD, Veith FJ, Schwartz ML, Dougherty MJ, DeLaurentis DA. Differences in early versus late extracavitary arterial graft infections. Journal of Vascular Surgery 1995; 22: 680–8
- Vogt PR, Von Segesser LK, Goffin Y, Niederhäuser U, Genoni M, Künzli A, et al. Eradication of aortic infections with the use of cryopreserved arterial homografts. Annals of Thoracic Surgery 1996; 62: 640–5
- Calligaro KD, Veith FJ, Yuan JG, Gargiulo NJ, Dougherty MJ. Intra-abdominal aortic graft infection: complete or partial graft preservation in patients at very high risk. Journal of Vascular Surgery 2003; 38: 1199–1205
- Coselli JS, Köksoy C, LeMaire SA. Management of thoracic aortic graft infections. Annals of Thoracic Surgery 1999; 67: 1990–3
- Calligaro KD, Veith FJ, Schwartz ML, Savarese RP, DeLaurentis DA. Are Gram-negative bacteria a contraindication to selective preservation of infected prosthetic arterial grafts?. Journal of Vascular Surgery 1992; 16: 337–46
- Nathwani D, Conlon C on behalf of the OHPAT UK Workshop. Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a working party. Clinical Microbiology and Infection 1998;4:537–51.
- Hoffmann-Terry ML, Fraimow HS, Fox TR, Swift BG, Wolf JE. Adverse effects of outpatient parenteral antibiotic therapy. The American Journal of Medicine 1999; 106: 44–9